Giulia Pinton

681 total citations
29 papers, 506 citations indexed

About

Giulia Pinton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Giulia Pinton has authored 29 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Giulia Pinton's work include Occupational and environmental lung diseases (15 papers), Pleural and Pulmonary Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Giulia Pinton is often cited by papers focused on Occupational and environmental lung diseases (15 papers), Pleural and Pulmonary Diseases (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Giulia Pinton collaborates with scholars based in Italy, United Kingdom and Sweden. Giulia Pinton's co-authors include Laura Moro, Luciano Mutti, Stefan Nilsson, Bruno Murer, Daniela Tavian, Dean A. Fennell, Riccardo Puntoni, Matteo Puntoni, Giovanni Gaudino and Antonio Daga and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Giulia Pinton

28 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Pinton Italy 15 219 215 119 79 52 29 506
Karen England United Kingdom 12 118 0.5× 326 1.5× 51 0.4× 26 0.3× 50 1.0× 15 541
Bryan M. Gillard United States 12 124 0.6× 320 1.5× 137 1.2× 65 0.8× 111 2.1× 25 615
Snehalata A. Pawar United States 14 59 0.3× 286 1.3× 82 0.7× 46 0.6× 67 1.3× 20 525
Alessandra de Cupis Italy 10 73 0.3× 201 0.9× 133 1.1× 84 1.1× 60 1.2× 15 363
Arunima Shilpi India 13 120 0.5× 428 2.0× 104 0.9× 55 0.7× 97 1.9× 17 726
Xiuling Li China 14 82 0.4× 228 1.1× 108 0.9× 30 0.4× 145 2.8× 29 468
Lokman Varışlı Türkiye 11 88 0.4× 261 1.2× 94 0.8× 18 0.2× 100 1.9× 28 410
Ming You United States 14 134 0.6× 501 2.3× 173 1.5× 90 1.1× 339 6.5× 25 742
Pamela L. Rice United States 12 74 0.3× 375 1.7× 176 1.5× 58 0.7× 110 2.1× 15 648
Zhongqi Li China 13 47 0.2× 222 1.0× 159 1.3× 101 1.3× 89 1.7× 20 520

Countries citing papers authored by Giulia Pinton

Since Specialization
Citations

This map shows the geographic impact of Giulia Pinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Pinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Pinton more than expected).

Fields of papers citing papers by Giulia Pinton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Pinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Pinton. The network helps show where Giulia Pinton may publish in the future.

Co-authorship network of co-authors of Giulia Pinton

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Pinton. A scholar is included among the top collaborators of Giulia Pinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Pinton. Giulia Pinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinton, Giulia, Nausicaa Clemente, Giulia Dematteis, et al.. (2024). EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure. Nutrients. 16(19). 3260–3260. 1 indexed citations
2.
3.
Fallarini, Silvia, Silvio Aprile, Valentina Audrito, et al.. (2023). A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment. International Journal of Molecular Sciences. 24(7). 6689–6689. 4 indexed citations
4.
Pinton, Giulia, et al.. (2023). Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma. Cancers. 15(5). 1537–1537. 3 indexed citations
5.
Gabano, Elisabetta, Ilaria Zanellato, Giulia Pinton, et al.. (2022). The Strange Case: The Unsymmetric Cisplatin‐Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier‐Mediated Cellular Uptake. Bioinorganic Chemistry and Applications. 2022(1). 3698391–3698391. 5 indexed citations
6.
7.
Pinton, Giulia, et al.. (2021). Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review. Journal of Thoracic Disease. 13(3). 1851–1863. 10 indexed citations
8.
Pinton, Giulia, Stefan Nilsson, & Laura Moro. (2018). Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality. Oncogenesis. 7(2). 15–15. 40 indexed citations
9.
Pinton, Giulia, Zejing Wang, Maria Felicia Soluri, et al.. (2017). Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia. Cell Death and Disease. 8(2). e2592–e2592. 22 indexed citations
10.
Pinton, Giulia, et al.. (2015). Lo fugaz y lo eterno. 35.
11.
Pinton, Giulia, Michele Cilli, Maurizio Rinaldi, et al.. (2015). Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells. Oncotarget. 6(28). 25121–25134. 11 indexed citations
12.
Pinton, Giulia, Antonio Daga, Michele Cilli, et al.. (2014). Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity. Molecular Cancer. 13(1). 227–227. 15 indexed citations
13.
Pinton, Giulia, et al.. (2013). Therapies currently in Phase II trials for malignant pleural mesothelioma. Expert Opinion on Investigational Drugs. 22(10). 1255–1263. 14 indexed citations
14.
Valenti, Daniela, Giulia Pinton, Puthen V. Jithesh, et al.. (2013). Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo. Oncogenesis. 2(9). e72–e72. 31 indexed citations
15.
Pinton, Giulia, et al.. (2012). Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma. PLoS ONE. 7(5). e36856–e36856. 34 indexed citations
16.
Pinton, Giulia, et al.. (2012). Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma. Expert Opinion on Medical Diagnostics. 6(3). 171–173. 4 indexed citations
17.
Pinton, Giulia, et al.. (2011). Coordinated Sumoylation and Ubiquitination Modulate EGF Induced EGR1 Expression and Stability. PLoS ONE. 6(10). e25676–e25676. 32 indexed citations
18.
Pinton, Giulia, Warren Thomas, Roberto E. Favoni, et al.. (2010). Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib. PLoS ONE. 5(11). e14110–e14110. 52 indexed citations
19.
Pinton, Giulia, et al.. (2009). Flavonoid-induced autophagy in hormone sensitive breast cancer cells. Fitoterapia. 80(6). 327–332. 15 indexed citations
20.
Pinton, Giulia, et al.. (2008). 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. The Journal of Steroid Biochemistry and Molecular Biology. 113(3-5). 163–170. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen England Breakdown of academic impact, for papers by Bryan M. Gillard Breakdown of academic impact, for papers by Snehalata A. Pawar Breakdown of academic impact, for papers by Alessandra de Cupis Breakdown of academic impact, for papers by Arunima Shilpi Breakdown of academic impact, for papers by Xiuling Li Breakdown of academic impact, for papers by Lokman Varışlı Breakdown of academic impact, for papers by Ming You Breakdown of academic impact, for papers by Pamela L. Rice Breakdown of academic impact, for papers by Zhongqi Li
Rankless by CCL
2026